Inflammatory Bowel Disease (IBD) Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: I80C178801FAEN
Market Monitor Global

Abstracts

Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.

This report contains market size and forecasts of Inflammatory Bowel Disease (IBD) Treatment in Global, including the following market information:

Global Inflammatory Bowel Disease (IBD) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Inflammatory Bowel Disease (IBD) Treatment market was valued at 13690 million in 2021 and is projected to reach US$ 15970 million by 2028, at a CAGR of 2.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

TNF Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inflammatory Bowel Disease (IBD) Treatment include AbbVie, Pfizer, Takeda, Janssen Biotech, Allergan, Bausch Health, Takeda Pharmaceutical, Novartis and Biogen. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Bowel Disease (IBD) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inflammatory Bowel Disease (IBD) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Bowel Disease (IBD) Treatment Market Segment Percentages, by Type, 2021 (%)

• TNF Inhibitors
• Aminosalicyclates
• Immunomodulators
• Corticosteroids

Global Inflammatory Bowel Disease (IBD) Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Bowel Disease (IBD) Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Inflammatory Bowel Disease (IBD) Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Inflammatory Bowel Disease (IBD) Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inflammatory Bowel Disease (IBD) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Inflammatory Bowel Disease (IBD) Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Pfizer
• Takeda
• Janssen Biotech
• Allergan
• Bausch Health
• Takeda Pharmaceutical
• Novartis
• Biogen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inflammatory Bowel Disease (IBD) Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT OVERALL MARKET SIZE

2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size: 2021 VS 2028
2.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Inflammatory Bowel Disease (IBD) Treatment Players in Global Market
3.2 Top Global Inflammatory Bowel Disease (IBD) Treatment Companies Ranked by Revenue
3.3 Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Inflammatory Bowel Disease (IBD) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Inflammatory Bowel Disease (IBD) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inflammatory Bowel Disease (IBD) Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Inflammatory Bowel Disease (IBD) Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease (IBD) Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Inflammatory Bowel Disease (IBD) Treatment Market Size Markets, 2021 & 2028
  4.1.2 TNF Inhibitors
  4.1.3 Aminosalicyclates
  4.1.4 Immunomodulators
  4.1.5 Corticosteroids
4.2 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue & Forecasts
  4.2.1 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue & Forecasts
  5.2.1 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue & Forecasts
  6.2.1 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2028
  6.3.2 US Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.3.3 Canada Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.3.4 Mexico Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2028
  6.4.2 Germany Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.4.3 France Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.4.4 U.K. Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.4.5 Italy Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.4.6 Russia Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.4.8 Benelux Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2028
  6.5.2 China Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.5.3 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.5.4 South Korea Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.5.6 India Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2028
  6.6.2 Brazil Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.6.3 Argentina Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2028
  6.7.2 Turkey Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.7.3 Israel Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028
  6.7.5 UAE Inflammatory Bowel Disease (IBD) Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.1.4 AbbVie Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.2.4 Pfizer Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Takeda
  7.3.1 Takeda Corporate Summary
  7.3.2 Takeda Business Overview
  7.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.3.4 Takeda Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.3.5 Takeda Key News
7.4 Janssen Biotech
  7.4.1 Janssen Biotech Corporate Summary
  7.4.2 Janssen Biotech Business Overview
  7.4.3 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.4.4 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.4.5 Janssen Biotech Key News
7.5 Allergan
  7.5.1 Allergan Corporate Summary
  7.5.2 Allergan Business Overview
  7.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.5.4 Allergan Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.5.5 Allergan Key News
7.6 Bausch Health
  7.6.1 Bausch Health Corporate Summary
  7.6.2 Bausch Health Business Overview
  7.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.6.4 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bausch Health Key News
7.7 Takeda Pharmaceutical
  7.7.1 Takeda Pharmaceutical Corporate Summary
  7.7.2 Takeda Pharmaceutical Business Overview
  7.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.7.4 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.7.5 Takeda Pharmaceutical Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.8.4 Novartis Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Biogen
  7.9.1 Biogen Corporate Summary
  7.9.2 Biogen Business Overview
  7.9.3 Biogen Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
  7.9.4 Biogen Inflammatory Bowel Disease (IBD) Treatment Revenue in Global Market (2017-2022)
  7.9.5 Biogen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Inflammatory Bowel Disease (IBD) Treatment Market Opportunities & Trends in Global Market
Table 2. Inflammatory Bowel Disease (IBD) Treatment Market Drivers in Global Market
Table 3. Inflammatory Bowel Disease (IBD) Treatment Market Restraints in Global Market
Table 4. Key Players of Inflammatory Bowel Disease (IBD) Treatment in Global Market
Table 5. Top Inflammatory Bowel Disease (IBD) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Inflammatory Bowel Disease (IBD) Treatment Product Type
Table 9. List of Global Tier 1 Inflammatory Bowel Disease (IBD) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease (IBD) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 32. AbbVie Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 35. Pfizer Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Corporate Summary
Table 37. Takeda Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 38. Takeda Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Biotech Corporate Summary
Table 40. Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 41. Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 44. Allergan Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bausch Health Corporate Summary
Table 46. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 47. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Takeda Pharmaceutical Corporate Summary
Table 49. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 50. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 53. Novartis Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Biogen Corporate Summary
Table 55. Biogen Inflammatory Bowel Disease (IBD) Treatment Product Offerings
Table 56. Biogen Inflammatory Bowel Disease (IBD) Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Inflammatory Bowel Disease (IBD) Treatment Segment by Type in 2021
Figure 2. Inflammatory Bowel Disease (IBD) Treatment Segment by Application in 2021
Figure 3. Global Inflammatory Bowel Disease (IBD) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Inflammatory Bowel Disease (IBD) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2021
Figure 8. By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 12. US Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 24. China Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Inflammatory Bowel Disease (IBD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogen Inflammatory Bowel Disease (IBD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)